Effects of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) by Composite Physiologic Index (CPI)

被引:0
作者
Nambiar, A. M. [1 ]
Molina-Molina, M. [2 ]
Padilla, M. [3 ]
Song, J. [4 ]
Mueller, H. [5 ]
Stowasser, S. [5 ]
Rohr, K. B. [5 ]
Wells, A. U. [6 ,7 ]
机构
[1] Univ Texas Hlth San Antonio, Div Pulm & Crit Care Med, Dept Med, San Antonio, TX USA
[2] Univ Hosp Bellvitge, ILD Unit, IDIBELL, Barcelona, Spain
[3] Icahn Sch Med Mt Sinai, Div Pulm Crit Care & Sleep Med, New York, NY 10029 USA
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Pulm & Crit Care Med, Seoul, South Korea
[5] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[6] Royal Brompton & Harefield NHS Fdn Trust, Natl Inst Hlth Res, Resp Biomed Res Unit, London, England
[7] Imperial Coll, Natl Heart & Lung Inst, London, England
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A1905
引用
收藏
页数:2
相关论文
共 50 条
[41]   Antifibrotics effects of nintedanib on lung fibroblasts derived from patients with progressive fibrosing intertitial lung diseases [J].
Joannes, Audrey ;
Morzadec, Claudie ;
Gutierrez, Francisco Llamas ;
Chiforeanu, Dan Cristian ;
De Latour, Bertrand Richard ;
Wollin, Lutz ;
Jouneau, Stephane ;
Vernhet, Laurent .
EUROPEAN RESPIRATORY JOURNAL, 2020, 56
[42]   Effects of nintedanib in patients with progressive fibrosing ILDs and differing baseline FVC: further analyses of the INBUILD trial [J].
Valenzuela, Claudia ;
Maher, Toby M. ;
Bonella, Francesco ;
Pesci, Alberto ;
Jouneau, Stephane ;
Patel, Nina M. ;
Perez, Evans R. Fernandez ;
Goeldner, Rainer-Georg ;
Stowasser, Susanne ;
Schlenker-Herceg, Rozsa ;
Quaresma, Manuel ;
Cottin, Vincent .
EUROPEAN RESPIRATORY JOURNAL, 2020, 56
[43]   Effect of Nintedanib in Patients with Systemic Sclerosis- Associated Interstitial Lung Disease (SSc-ILD) by Composite Physiologic Index (CPI) at Baseline [J].
Wells, A. U. ;
Highland, K. B. ;
Glaeser, S. ;
Nunes, H. ;
Song, J. W. ;
Wuyts, W. A. ;
Stock, C. ;
Alves, M. ;
Padilla, M. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
[44]   Effects of nintedanib on progression of ILD in patients with fibrosing ILDs and a progressive phenotype: further analyses of the INBUILD trial [J].
Flaherty, Kevin R. ;
Wells, Athol U. ;
Cottin, Vincent ;
Devaraj, Anand ;
Inoue, Yoshikazu ;
Richeldi, Luca ;
Walsh, Simon L. F. ;
Kolb, Martin ;
Koschel, Dirk ;
Moua, Teng ;
Stowasser, Susanne ;
Goeldner, Rainer-Georg ;
Schlenker-Herceg, Rozsa ;
Brown, Kevin K. .
EUROPEAN RESPIRATORY JOURNAL, 2020, 56
[45]   Continued nintedanib treatment in patients with progressive fibrosing ILDs: interim analysis of INBUILD-ON [J].
Bonella, F. ;
Wuyts, A. W. ;
Chaudhuri, N. ;
Varone, F. ;
Antin-Ozerkis, D. ;
Mueller, H. ;
Coeck, C. ;
Rohr, B. K. ;
Cottin, V .
PNEUMOLOGIE, 2022, 76 :S25-S26
[46]   Continued nintedanib treatment in patients with progressive fibrosing ILDs: interim analysis of INBUILD-ON [J].
Wuyts, Wim A. ;
Bonella, Francesco ;
Chaudhuri, Nazia ;
Varone, Francesco ;
Antin-Ozerkis, Danielle ;
Mueller, Heiko ;
Coeck, Carl ;
Rohr, Klaus B. ;
Cottin, Vincent .
EUROPEAN RESPIRATORY JOURNAL, 2021, 58
[47]   Continued nintedanib treatment in patients with progressive fibrosing ILDs: interim analysis of INBUILD-ON [J].
Wuyts, W. A. ;
Bonella, F. ;
Chaudhuri, N. ;
Varone, F. ;
Antin-Ozerkis, D. ;
Mueller, H. ;
Coeck, C. ;
Rohr, K. B. ;
Cottin, V .
EUROPEAN RESPIRATORY JOURNAL, 2022, 60
[48]   EFFECT OF NINTEDANIB IN PATIENTS WITH PROGRESSIVE FIBROSING ILDS AND PRESERVED LUNG FUNCTION AT BASELINE: FURTHER ANALYSES OF THE INBUILD TRIAL [J].
Patel, Nina ;
Kaner, Robert ;
Cerri, Stefania ;
Inoue, Yoshikazu ;
Mueller, Heiko ;
Rohr, Klaus ;
Stowasser, Susanne ;
Kolb, Martin .
CHEST, 2020, 158 (04) :1051A-1052A
[49]   Progressive fibrosing interstitial lung diseases (PF-ILDs): prevalence and characterization in two Italian referral centers [J].
Faverio, Paola ;
Cassandro, Roberto ;
Piluso, Martina ;
De Giacomi, Federica ;
Della Zoppa, Matteo ;
Harari, Sergio Alfonso ;
Luppi, Fabrizio ;
Pesci, Alberto .
EUROPEAN RESPIRATORY JOURNAL, 2020, 56
[50]   Safety and tolerability of nintedanib in patients with progressive fibrosing interstitial lung diseases: data from the randomized controlled INBUILD trial [J].
Vincent Cottin ;
Fernando J. Martinez ;
R. Gisli Jenkins ;
John A. Belperio ;
Hideya Kitamura ;
Maria Molina-Molina ;
Inga Tschoepe ;
Carl Coeck ;
Dirk Lievens ;
Ulrich Costabel .
Respiratory Research, 23